Optimizing low-density lipoprotein cholesterol (LDL-C) management – a US physician survey of barriers and burdens

20251 citationsJournal Articlegold Open Access

Authors

Lawrence A. Leiter · St. Michael's Hospital

Taruja Karmarkar · Merck & Co., Inc., Rahway, NJ, USA (United States)

Lori D. Bash · Merck & Co., Inc., Rahway, NJ, USA (United States)

Jason Exter · Merck & Co., Inc., Rahway, NJ, USA (United States)

Jordana K. Schmier · Open Health Systems Laboratory

Sayeli Jayade · Open Health Systems Laboratory

Kyle C. Roney

Abstract

Our findings suggest patient, clinician, and system barriers may all hinder LDL-C management and adherence. A greater understanding of the association between perceived barriers and real-world behaviors will help optimize lipid management.

Topics & Keywords

Lipoproteins and Cardiovascular Health Medication Adherence and Compliance Diabetes, Cardiovascular Risks, and Lipoproteins

Publication Details

Published in: American Journal of Preventive Cardiology

Volume 25, pp. 101386-101386

DOI: 10.1016/j.ajpc.2025.101386

Field-Weighted Citation Impact: 2.07

Command Palette

Optimizing low-density lipoprotein cholesterol (LDL-C) management – a US physician survey of barriers and burdens

Authors

Abstract

Topics & Keywords

Publication Details